Literature DB >> 10220340

Arg352 is a major determinant of charge selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel.

R Guinamard1, M H Akabas.   

Abstract

The cystic fibrosis transmembrane conductance regulator forms an anion-selective channel. We previously showed that charge selectivity, the ability to discriminate between anions and cations, occurs near the cytoplasmic end of the channel. The molecular determinants of charge selectivity, however, are unknown. We investigated the role of Arg352, a residue flanking the predicted cytoplasmic end of the M6 segment, in the mechanism of charge selectivity. We determined the Cl- to Na+ permeability ratio (PCl/PNa) from the reversal potential measured in a 10-fold NaCl gradient. For the wild type, PCl/PNa was 36 (range of 28-51). For the R352H mutant, PCl/PNa was dependent on cytoplasmic pH. At pH 5.4, the PCl/PNa was 33 (range of 27-41), similar to that of the wild type, but at pH 7.2, where the histidine should be largely uncharged, PCl/PNa was 3 (range of 2.9-3.1). For the R352C and R352Q mutants, PCl/PNa was 7 (range of 6-8) and 4 (range of 3.5-4.4), respectively. Furthermore, Na+ which does not carry a significant fraction of the current through the wild type is measurably conducted through R352Q. Thus, the charge of the side chain at position 352 is a strong determinant of charge selectivity. In the wild type, the positive charge on Arg352 contributes to an electrostatic potential in the channel that forms a barrier to cation permeation. Mutation of Arg352 did not alter the halide selectivity sequence. Selectivity among halides must involve other residues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220340     DOI: 10.1021/bi990155n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Protonation of lysine residues inverts cation/anion selectivity in a model channel.

Authors:  V Borisenko; M S Sansom; G A Woolley
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

2.  Molecular determinants of Au(CN)(2)(-) binding and permeability within the cystic fibrosis transmembrane conductance regulator Cl(-) channel pore.

Authors:  Xiandi Gong; Susan M Burbridge; Elizabeth A Cowley; Paul Linsdell
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

3.  Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers.

Authors:  Guiying Cui; Binlin Song; Hussein W Turki; Nael A McCarty
Journal:  Pflugers Arch       Date:  2011-12-13       Impact factor: 3.657

4.  The intrinsic electrostatic potential and the intermediate ring of charge in the acetylcholine receptor channel.

Authors:  G G Wilson; J M Pascual; N Brooijmans; D Murray; A Karlin
Journal:  J Gen Physiol       Date:  2000-02       Impact factor: 4.086

5.  Molecular determinants of anion selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Authors:  P Linsdell; A Evagelidis; J W Hanrahan
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

6.  Cystic fibrosis transmembrane conductance regulator: using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the pore.

Authors:  Christopher Alexander; Anthony Ivetac; Xuehong Liu; Yohei Norimatsu; Jose R Serrano; Allison Landstrom; Mark Sansom; David C Dawson
Journal:  Biochemistry       Date:  2009-10-27       Impact factor: 3.162

7.  Molecular models of the open and closed states of the whole human CFTR protein.

Authors:  Jean-Paul Mornon; Pierre Lehn; Isabelle Callebaut
Journal:  Cell Mol Life Sci       Date:  2009-08-26       Impact factor: 9.261

8.  Stable dimeric assembly of the second membrane-spanning domain of CFTR (cystic fibrosis transmembrane conductance regulator) reconstitutes a chloride-selective pore.

Authors:  Mohabir Ramjeesingh; Francisca Ugwu; Canhui Li; Sonja Dhani; Ling Jun Huan; Yanchun Wang; Christine E Bear
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

9.  Mutations at arginine 352 alter the pore architecture of CFTR.

Authors:  Guiying Cui; Zhi-Ren Zhang; Andrew R W O'Brien; Binlin Song; Nael A McCarty
Journal:  J Membr Biol       Date:  2008-04-18       Impact factor: 1.843

Review 10.  Structural mechanisms of CFTR function and dysfunction.

Authors:  Tzyh-Chang Hwang; Jiunn-Tyng Yeh; Jingyao Zhang; Ying-Chun Yu; Han-I Yeh; Samantha Destefano
Journal:  J Gen Physiol       Date:  2018-03-26       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.